glp 1 agonist clinical trials Timeline of GLP-1 discovery and development. (a) Key events in Issue 42: GLP-1 RA Drug
Description
Headaches: Common in the first week or two, usually resolving as the body adjusts
DPP-4 inhibitors have a half-life of 12.4 to 24 hours and are dosed once daily
Obesity in adults
Traditional thinking treated glucagon as purely counterregulatory to insulin blocking glucagon would help glycemic control
However, many Type 2 diabetics will not achieve sufficient control of their blood sugar on metformin alone and will be placed on one or more additional therapies, as outlined in the previously mentioned treatment guidelines
These regular check-ins help guide whether your dose should stay the same, increase slightly, or, in some cases, decrease to keep things manageable
